RAFAEL HOLDINGS, INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
RAFAEL HOLDINGS, INC. (RFL) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $23.10 million as of 2018-07-31, per its 10-K filed 2018-10-15.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2018-10-15
- 2018-07-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $23.10M.
- 2018-04-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $28.12M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value |
|---|---|
| 2018-07-31 | $23.10M 10-K · filed 2018-10-15 |
| 2018-04-30 | $28.12M 10-Q · filed 2018-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |